{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:14:18Z","timestamp":1780373658431,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP20\/00120"],"award-info":[{"award-number":["CP20\/00120"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00323"],"award-info":[{"award-number":["PI18\/00323"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011597","name":"Generalitat Valenciana Conselleria de Sanitat","doi-asserted-by":"publisher","award":["ACIF\/2019\/139"],"award-info":[{"award-number":["ACIF\/2019\/139"]}],"id":[{"id":"10.13039\/501100011597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011597","name":"Generalitat Valenciana Conselleria de Sanitat","doi-asserted-by":"publisher","award":["APOSTD\/2020\/123"],"award-info":[{"award-number":["APOSTD\/2020\/123"]}],"id":[{"id":"10.13039\/501100011597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011597","name":"Generalitat Valenciana Conselleria de Sanitat","doi-asserted-by":"publisher","award":["PROMETEO\/2018\/137"],"award-info":[{"award-number":["PROMETEO\/2018\/137"]}],"id":[{"id":"10.13039\/501100011597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.fertnstert.2021.10.012","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T14:30:11Z","timestamp":1637332211000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma"],"prefix":"10.1016","volume":"117","author":[{"given":"Mar\u00eda Cristina","family":"Carbajo-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaira","family":"Garc\u00eda-Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Corach\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Monle\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6208-5319","authenticated-orcid":false,"given":"Alexandra","family":"Trelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Faus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.10.012_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1471-0528.2003.00002.x","article-title":"Controversies and challenges in the modern management of uterine fibroids","volume":"111","author":"Manyonda","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2015.11.018","article-title":"The epidemiology and genetics of uterine leiomyoma","volume":"34","author":"Styer","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jcma.2012.07.004","article-title":"Typical and atypical clinical presentation of uterine myomas","volume":"75","author":"Su","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5926470","article-title":"Myomas and adenomyosis: impact on reproductive outcome","volume":"2017","author":"Vlahos","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib9","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1177\/0300060519858027","article-title":"Comparison of clinical outcomes and postoperative quality of life after surgical treatment of type II submucous myoma via laparoscopy or hysteroscopy","volume":"47","author":"Zhang","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0015-0282(16)60568-X","article-title":"Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study","volume":"51","author":"Friedman","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)03154-0","article-title":"Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata","volume":"78","author":"Sozen","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib14","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00404-017-4515-5","article-title":"Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease","volume":"296","author":"Lagan\u00e0","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1933719115584449","article-title":"The mechanism and function of epigenetics in uterine leiomyoma development","volume":"23","author":"Yang","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108927","article-title":"Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution","volume":"34","author":"Leistico","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41467-020-14701-6","article-title":"Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas","volume":"11","author":"Moyo","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tranon.2017.01.010","article-title":"microRNA-489 plays an anti-metastatic role in human hepatocellular carcinoma by targeting matrix metalloproteinase-7","volume":"10","author":"Lin","year":"2017","journal-title":"Transl Oncol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1139\/o05-041","article-title":"Role of histone acetylation in the control of gene expression","volume":"83","author":"Verdone","year":"2005","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1186\/s12885-015-1761-4","article-title":"The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models","volume":"15","author":"Hervouet","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ncb3582","article-title":"ARID1A-mutated ovarian cancers depend on HDAC6 activity","volume":"19","author":"Bitler","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/09513590.2017.1301924","article-title":"dos S, Brum IS, Branchini G, Pizzolato LS, Capp E, Corleta H von E. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells","volume":"33","author":"Sant\u2019Anna","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/humrep\/der203","article-title":"Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target","volume":"26","author":"Kawano","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/CAD.0000000000000597","article-title":"Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in\u00a0vitro and in\u00a0vivo","volume":"29","author":"Wei","year":"2018","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib29","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1267\/ahc.18044","article-title":"The HDAC inhibitor, SAHA, combined with cisplatin synergistically induces apoptosis in alpha-fetoprotein-producing hepatoid adenocarcinoma cells","volume":"52","author":"Kyaw","year":"2019","journal-title":"Acta Histochem Cytochem"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/cells8121480","article-title":"Adjuvant epigenetic therapy of decitabine and suberoylanilide hydroxamic acid exerts anti-neoplastic effects in acute myeloid leukemia cells","volume":"8","author":"Abou Najem","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib33","first-page":"5165","article-title":"Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in\u00a0vitro and in\u00a0vivo","volume":"60","author":"Butler","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pharmtox-010716-105106","article-title":"Targeting epigenetics in cancer","volume":"58","author":"Bennett","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib35","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/medicina55020030","article-title":"Cell cycle arrest and cytotoxic effects of saha and rg7388 mediated through p21waf1\/cip1and p27kip1in cancer cells","volume":"55","author":"Natarajan","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib38","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.3748\/wjg.v19.i31.5159","article-title":"Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib39","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/cancers11101587","article-title":"Histone deacetylase expressions in hepatocellular carcinoma and functional effects of histone deacetylase inhibitors on liver cancer cells in\u00a0vitro","volume":"11","author":"Freese","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.onc.1210204","article-title":"Discovery and development of SAHA as an anticancer agent","volume":"26","author":"Marks","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cmdc.201300413","article-title":"Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next","volume":"9","author":"Thaler","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1933719111398147","article-title":"Histone deacetylase 6 regulates estrogen receptor \u03b1 in uterine leiomyoma","volume":"18","author":"Wei","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib43","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib44","doi-asserted-by":"crossref","first-page":"E1517","DOI":"10.1210\/clinem\/dgz227","article-title":"Activation of \u03b2-catenin signaling and its crosstalk with estrogen and histone deacetylases in human uterine fibroids","volume":"105","author":"Ali","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1933719118768692","article-title":"Regulation of cell cycle regulatory proteins by microRNAs in uterine leiomyoma","volume":"26","author":"Chuang","year":"2019","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib46","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib47","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1365-2133.2010.09947.x","article-title":"Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours","volume":"163","author":"Mart\u00edn-Ezquerra","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib48","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium","volume":"82","author":"Leppert","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","article-title":"1,25-Dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model","volume":"86","author":"Halder","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.fertnstert.2019.09.018","article-title":"Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model","volume":"113","author":"Corach\u00e1n","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib52","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib53","first-page":"95","article-title":"Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice","volume":"41","author":"Nguy\u00ean-Thanh","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib54","first-page":"913","article-title":"Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-\u03b23 (TGF\u03b23) and altered responses to the antiproliferative effects of TGF\u03b2 1","volume":"86","author":"Lee","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib55","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.fertnstert.2018.12.026","article-title":"Ulipristal acetate decreases active TGF-\u03b23 and its canonical signaling in uterine leiomyoma via two novel mechanisms","volume":"111","author":"Lewis","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.fertnstert.2020.07.049","article-title":"Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation","volume":"115","author":"Corach\u00e1n","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0301-2115(03)00244-6","article-title":"Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp","volume":"111","author":"Inagaki","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/cancers11050726","article-title":"Epigenetic reprogramming of TGF-\u03b2 signaling in breast cancer","volume":"11","author":"Suriyamurthy","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.matbio.2010.05.002","article-title":"HDAC-mediated control of ERK- and PI3K-dependent TGF-\u03b2-induced extracellular matrix-regulating genes","volume":"29","author":"Barter","year":"2010","journal-title":"Matrix Biol"},{"key":"10.1016\/j.fertnstert.2021.10.012_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030508","article-title":"Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion","volume":"7","author":"Estella","year":"2012","journal-title":"PLoS One"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502822102135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502822102135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:32:03Z","timestamp":1758011523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502822102135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S001502822102135X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.10.012","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}